American Society of Gene and Cell Therapy Annual Meeting 2024

In the vanguard of medical advancement, the innovation within cell therapy clinical trials is not merely a progression but a quantum leap forward in patient care, offering transformative and enduring treatments. At Syneos Health, we are not just participants but catalysts of this seismic shift.  

Our Cell and Gene Therapy Development Engine is the nexus of our innovative spirit, driving us to overcome the most daunting of challenges. It is our commitment to ensure that from conception to delivery, these pioneering therapies reach patients, redefining what is possible in medicine.  

Meet with Us

Meet Meet with us at the ASGCT Annual Meeting to discuss how our collective knowledge and insights can be fully leveraged to deliver solutions specific to the needs of your trial—and make each study as safe and effective for patients as possible.   

Speaker Sessions

Unlocking the Promise of Genetic Medicines: From Clinical to Commercial Development | May 10th from 3:45 – 4:15 PM | Room 337-338

Related Content

Want to learn more? Explore Insights Hub for our latest perspectives, subscribe to our podcast, or click the resources below: 

A Holistic Approach to Genetic Medicines is Next for the Life Science Industry  

Exploring an Expedited Regulatory Pathway for Cell and Gene Therapies    

Cell and Gene Therapy Sponsors Must Overcome Unique Hurdles to Realize Promise to Patients    

Strategies for Small Biotech in the Development of Cell Therapy Trials    

View more of our insights on Cell & Gene Therapy.   

Learn more about our Cell & Gene Therapy expertise.